Martha Grogan

21.5k total citations · 4 hit papers
187 papers, 8.1k citations indexed

About

Martha Grogan is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Martha Grogan has authored 187 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Molecular Biology, 75 papers in Nephrology and 56 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Martha Grogan's work include Amyloidosis: Diagnosis, Treatment, Outcomes (144 papers), Parathyroid Disorders and Treatments (72 papers) and Peptidase Inhibition and Analysis (27 papers). Martha Grogan is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (144 papers), Parathyroid Disorders and Treatments (72 papers) and Peptidase Inhibition and Analysis (27 papers). Martha Grogan collaborates with scholars based in United States, Italy and United Kingdom. Martha Grogan's co-authors include Angela Dispenzieri, Morie A. Gertz, Mathew S. Maurer, Frederick L. Ruberg, Mazen Hanna, Robert A. Kyle, Jeffery W. Kelly, Kyle W. Klarich, Bernard J. Gersh and Hugh C. Smith and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Martha Grogan

170 papers receiving 7.9k citations

Hit Papers

Transthyretin Amyloid Cardiomyopathy 2016 2026 2019 2022 2019 2016 2019 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Transthyretin Amyloid Cardiomyopathy
    2019 633 citations Frederick L. Ruberg, Martha Grogan et al. Journal of the American College of Cardiology profile →
  2. Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System
    2016 475 citations Martha Grogan, Christopher G. Scott et al. Journal of the American College of Cardiology profile →
  3. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
    2019 331 citations Mathew S. Maurer, Thibaud Damy et al. profile →
  4. Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis
    2019 316 citations Scott D. Solomon, David Adams et al. Circulation profile →

Peers

Martha Grogan
John L. Berk United States
Arnt V. Kristen Germany
Thomas A. Treibel United Kingdom
Michel Slama France
Dominique Chauveau France
Tobias Carling United States
Patrick Collier United States
Bénédicte Hugel France
Elena Biagini Italy
Piero Berti Italy
John L. Berk United States
Martha Grogan
Citations per year, relative to Martha Grogan Martha Grogan (= 1×) peers John L. Berk

Countries citing papers authored by Martha Grogan

Since Specialization
Citations

This map shows the geographic impact of Martha Grogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Grogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Grogan more than expected).

Fields of papers citing papers by Martha Grogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Grogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Grogan. The network helps show where Martha Grogan may publish in the future.

Co-authorship network of co-authors of Martha Grogan

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Grogan. A scholar is included among the top collaborators of Martha Grogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Grogan. Martha Grogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Judge, Daniel P., Kevin Alexander, Francesco Cappelli, et al.. (2025). Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 85(10). 1003–1014. 7 indexed citations
2.
3.
Tersalvi, Gregorio, Christopher G. Scott, Jun Zhang, et al.. (2025). Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-Hour 99m Tc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison. Circulation Cardiovascular Imaging. 19(1). e018745–e018745.
4.
Netzel, Brian C., M. Cristine Charlesworth, Kenneth L. Johnson, et al.. (2025). Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damage. Amyloid. 32(1). 72–80.
5.
6.
Dasari, Surendra, Jason D. Theis, Matthew T. Howard, et al.. (2025). Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patients. Human Pathology. 166. 105954–105954.
7.
Gentile, Luca, Igor Diemberger, Violaine Planté‐Bordeneuve, et al.. (2024). Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS). PLoS ONE. 19(1). e0292435–e0292435. 2 indexed citations
8.
González-López, Esther, Ellen D. McPhail, Clara Salas, et al.. (2024). Histological Typing in Patients With Cardiac Amyloidosis. Journal of the American College of Cardiology. 83(11). 1085–1099. 14 indexed citations
9.
Grogan, Martha, Margot K. Davis, María G. Crespo‐Leiro, et al.. (2024). Effect of Long-Term Tafamidis Treatment on Health-Related Quality of Life in Patients with Transthyretin Amyloid Cardiomyopathy. European Journal of Heart Failure. 26(3). 612–615. 4 indexed citations
10.
Chao, Chieh‐Ju, Jiwoong Jeong, Reza Arsanjani, et al.. (2023). Echocardiography-Based Deep Learning Model to Differentiate Constrictive Pericarditis and Restrictive Cardiomyopathy. JACC. Cardiovascular imaging. 17(4). 349–360. 18 indexed citations
11.
Harmon, David, Christopher G. Scott, Dennis H. Murphree, et al.. (2023). Postdevelopment Performance and Validation of the Artificial Intelligence-Enhanced Electrocardiogram for Detection of Cardiac Amyloidosis. JACC Advances. 2(8). 100612–100612. 18 indexed citations
12.
Minnema, Monique C., Angela Dispenzieri, Giampaolo Merlini, et al.. (2022). Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis. JACC CardioOncology. 4(4). 474–487. 12 indexed citations
13.
Grogan, Martha, Francisco López-Jiménez, Michal Cohen‐Shelly, et al.. (2021). Artificial Intelligence–Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clinic Proceedings. 96(11). 2768–2778. 76 indexed citations
14.
Solomon, Scott D., David Adams, Arnt V. Kristen, et al.. (2019). Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis. Circulation. 139(4). 431–443. 316 indexed citations breakdown →
15.
Lee, Seung‐Pyo, Jun‐Bean Park, Hyung‐Kwan Kim, et al.. (2019). Contemporary Imaging Diagnosis of Cardiac Amyloidosis. PubMed. 27(1). 1–1. 22 indexed citations
16.
Gillmore, Julian D., Pablo García‐Pavía, Martha Grogan, et al.. (2019). Abstract 14214: ATTRibute-CM: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Phase 3 Study of AG10 in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM). Circulation. 5 indexed citations
17.
Judge, Daniel P., Stephen B. Heitner, Rodney H. Falk, et al.. (2019). Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. Journal of the American College of Cardiology. 74(3). 285–295. 180 indexed citations
18.
Saiki, Hirofumi, Benjamin W. Eidem, Tomohito Ohtani, Martha Grogan, & Margaret M. Redfield. (2016). Ventricular‐Arterial Function and Coupling in the Adult Fontan Circulation. Journal of the American Heart Association. 5(9). 34 indexed citations
19.
Feng, DaLi, William D. Edwards, Jae K. Oh, et al.. (2007). Intracardiac Thrombosis and Embolism in Patients With Cardiac Amyloidosis. Circulation. 116(21). 2420–2426. 185 indexed citations
20.
Beauchesne, Luc, Carole A. Warnes, Heidi M. Connolly, et al.. (2005). Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. Journal of the American College of Cardiology. 45(4). 595–598. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. Berk Breakdown of academic impact, for papers by Arnt V. Kristen Breakdown of academic impact, for papers by Thomas A. Treibel Breakdown of academic impact, for papers by Michel Slama Breakdown of academic impact, for papers by Dominique Chauveau Breakdown of academic impact, for papers by Tobias Carling Breakdown of academic impact, for papers by Patrick Collier Breakdown of academic impact, for papers by Bénédicte Hugel Breakdown of academic impact, for papers by Elena Biagini Breakdown of academic impact, for papers by Piero Berti
Rankless by CCL
2026